0001214659-22-000267.txt : 20220104
0001214659-22-000267.hdr.sgml : 20220104
20220104182039
ACCESSION NUMBER: 0001214659-22-000267
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211231
FILED AS OF DATE: 20220104
DATE AS OF CHANGE: 20220104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chappell Dale
CENTRAL INDEX KEY: 0001379459
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35798
FILM NUMBER: 22508254
MAIL ADDRESS:
STREET 1: C/O OPUS EQUUM INC.
STREET 2: PO BOX 788
CITY: DOLORES
STATE: CO
ZIP: 81323
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HUMANIGEN, INC
CENTRAL INDEX KEY: 0001293310
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770557236
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 533 AIRPORT BLVD.
STREET 2: SUITE 400
CITY: BURLINGAME
STATE: CA
ZIP: 94010
BUSINESS PHONE: 650.243.3100
MAIL ADDRESS:
STREET 1: 533 AIRPORT BLVD.
STREET 2: SUITE 400
CITY: BURLINGAME
STATE: CA
ZIP: 94010
FORMER COMPANY:
FORMER CONFORMED NAME: KALOBIOS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20040609
4
1
marketforms-54937.xml
PRIMARY DOCUMENT
X0306
4
2021-12-31
0001293310
HUMANIGEN, INC
HGEN
0001379459
Chappell Dale
C/O OPUS EQUUM INC
P.O. BOX 788
DOLORES
CO
81323
true
true
true
false
Chief Scientific Officer
Stock Option (Right to Buy)
3.72
2021-12-31
4
A
false
44600
0
A
2022-03-31
2031-12-30
Common Stock
44600
44600
D
The option vests in 12 ratable quarterly installments commencing March 31, 2022.
/s/ Dale Chappell
2022-01-04